---
title: "FMC Corp 1Q 2026: Revenue $758.6M, EPS ($2.25) — 10-Q Summary"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284821794.md"
description: "FMC Corp reported a revenue of $758.6M for Q1 2026, down 4.1% from $791.4M a year ago, with a net loss of $281.3M, or ($2.25) per share, compared to a loss of $15.5M, or ($0.12) per share in the prior year. EMEA revenue grew 13%, while North America rose 6%. The company is restructuring with Project Foundation and has classified its India commercial business as held for sale."
datetime: "2026-04-30T19:01:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284821794.md)
  - [en](https://longbridge.com/en/news/284821794.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284821794.md)
---

# FMC Corp 1Q 2026: Revenue $758.6M, EPS ($2.25) — 10-Q Summary

FMC Corp reported first-quarter 2026 results with revenue of $758.6M, down from $791.4M a year earlier, and a net loss attributable to FMC stockholders of $281.3M, or diluted loss per share of ($2.25), versus a loss of $15.5M, or ($0.12) in the prior-year quarter.

**Financial Highlights**

Metric

Current quarter

Prior year quarter

YoY change

Revenue¹

$758.6M

$791.4M

(4.1%)

Net income²

($281.3M)

($15.5M)

(1714.8%)

Diluted EPS³

($2.25)

($0.12)

(1775%)

_¹ Reported as “Revenue”. ² Reported as “Net income (loss) attributable to FMC stockholders”. ³ Reported as “Diluted earnings (loss) per common share attributable to FMC stockholders”._

**Business Highlights**

-   Revenue declined about 4% year-over-year, with pricing pressure offsetting volume gains in EMEA and North America.
-   Regional performance: EMEA grew ~13% driven by volume, North America rose ~6%, while Latin America and Asia fell, with Asia down about 39%.
-   Branded herbicides and Cyazypyr® showed momentum; the company is managing a post-patent transition for Rynaxypyr® and advancing new active ingredients.
-   FMC classified its India commercial business as held for sale, planning a supply agreement while manufacturing remains in India.
-   Launched Project Foundation, a multi-year cost optimization and restructuring program including asset exits and operational reshaping.

Original SEC Filing: FMC CORP \[ FMC \] - 10-Q - Apr. 30, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [FMC.US](https://longbridge.com/en/quote/FMC.US.md)
- [VEGI.US](https://longbridge.com/en/quote/VEGI.US.md)
- [DBA.US](https://longbridge.com/en/quote/DBA.US.md)

## Related News & Research

- [If you'd invested in FMC stock 5 years ago, here's how much you'd have today (spoiler: it's not pretty)](https://longbridge.com/en/news/286571982.md)
- [FMC Corporation CEO Pierre Brondeau and CFO Andrew Sandifer to speak at BMO Global Farm to Market Chemicals Conference | FMC Stock News](https://longbridge.com/en/news/285933261.md)
- [Cibus Q1 revenue rises and beats analyst estimates](https://longbridge.com/en/news/286463305.md)
- [FMC Corporation Stock 12‑Month Price Target Cut to $17.06, Implies 15% Upside](https://longbridge.com/en/news/285602796.md)
- [FMC Corp’s Forward-Looking Statements Pose Transparency and Risk Assessment Challenges for Investors](https://longbridge.com/en/news/284957855.md)